Erratum to: Evidence for decreased expression of APPL1 associated with reduced insulin and adiponectin receptors expression in PCOS patients.

OA: closed
Full text JSON View on PubMed View at publisher
AI-generated summary by claude@2026-07+body, 2026-07-17

This erratum corrects the spelling of author Prof. M. Mehdizadeh's name in the original article regarding APPL1 and receptor expression in PCOS patients.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-07, 2026-07-17 · read from full text

This document is an erratum to a previously published article investigating decreased APPL1 expression in relation to insulin and adiponectin receptor expression in patients with PCOS. The only content provided here is correction of an author’s name, stating that Prof. Mehdizadeh was incorrectly published in the original article and should appear as Prof. M. Mehdizadeh. No additional experimental findings, results, or limitations from the original study are described in this erratum. The paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Full text 776 characters · extracted from oa-doi-fallback · click to expand
Erratum to: J Endocrinol Invest DOI 10.1007/s40618-016-0468-y Unfortunately, Prof. Mehdizadeh name was wrongly published in the original article. The complete correct name is Prof. M. Mehdizadeh. Author information Authors and Affiliations Corresponding author Additional information The online version of the original article can be found under doi:10.1007/s40618-016-0468-y. Rights and permissions About this article Cite this article Dehghan, R., Saidijam, M., Mehdizadeh, M. et al. Erratum to: Evidence for decreased expression of APPL1 associated with reduced insulin and adiponectin receptors expression in PCOS patients. J Endocrinol Invest 39, 1083 (2016). https://doi.org/10.1007/s40618-016-0490-0 Published: Issue date: DOI: https://doi.org/10.1007/s40618-016-0490-0

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-08-09T06:10:49.860119+00:00